Journal of Clinical Pediatrics >
Clinical and genetic variation analysis of A20 haploinsufficiency presented as refractory diarrhea in three children
Received date: 2022-10-24
Online published: 2023-11-08
Objective To analyze the clinical characteristics and TNFAIP3 gene variation of 3 patients with A20 haploinsufficiency of A20 (HA20), so as to provide clues for clinical diagnosis and treatment. Methods The clinical manifestations, laboratory data and digestive endoscopy changes of 3 patients were collected. Whole exome sequencing (WES) was performed on the patients and their parents, and the pathogenic variants were verified by Sanger sequencing. Results All 3 patients were female, and the minimum age of onset was 13 days after birth. No ocular lesions were found in any of the patients who presented with fever, diarrhea, and mucosa-stained feces. Digestive endoscopy in patient 1 showed frost-like ulcers of the duodenum bulb, hemorrhagic gastritis, multiple ulcers in the jejunum and lower ileum, and colonoscopy revealed red hyperaemia in the ileocecum. Digestive endoscopy of patient 2 showed no abnormalities in the stomach and small intestine, and multiple ulcers were found in multiple ulcers in colon. Patient 3 did not undergo digestive endoscopy. WES showed that all patients carried heterozygous variants of TNFAIP3 gene: c.811C>T, p.R271X (spontaneous variant), c.292_295dup, p.G99EfsX3 (a variant inherited from mother) and c.133C>T, p.R45X (a variant inherited from mother). According to ACMG (American College of Medical Genetics and Genomics) guidelines, they are classified as pathogenic variation, suspected pathogenic variation, and pathogenic variation, respectively. Patient 1 was treated with methylprednisolone which was ineffective, and was then treated with infliximab; patient 2 was given adalimumab after methylprednisolone-induced remission, and patient 3 was switched to thalidomide after methylprednisolone-induced remission. The clinical symptoms of 3 patients were relieved, and their growth and development were improved. Conclusion Children with recurrent fever, oral ulcers and refractory diarrhea should be alert to HA20, and genetic testing of suspected patients is helpful for early diagnosis.
Haiyan FU , Li MA , Weina SHI , Gelan BAI , Min SUN , Yali LIU , Lijuan CHENG , Xiaoyun JIA , Guigui LI , Shiguang ZHAO , Xiaolei LI , Yaofang XIA , Ruiqin ZHAO . Clinical and genetic variation analysis of A20 haploinsufficiency presented as refractory diarrhea in three children[J]. Journal of Clinical Pediatrics, 2023 , 41(11) : 839 -845 . DOI: 10.12372/jcp.2023.22e1398
| [1] | Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease[J]. Nat Genet, 2016, 48(1): 67-73. |
| [2] | Catrysse L, Vereecke L, Beyaert R, et al. A20 in inflammation and autoimmunity[J]. Trends Immunol, 2014, 35(1): 22-31. |
| [3] | Aeschlimann FA, Laxer RM. Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement[J]. Curr Opin Rheumatol, 2018, 30(5): 506-513. |
| [4] | Aeschlimann FA, Batu ED, Canna SW, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease[J]. Ann Rheum Dis, 2018, 77(5): 728-735. |
| [5] | Kadowaki T, Ohnishi H, Kawamoto N, et al. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders[J]. J Allergy Clin Immunol, 2018, 141(4): 1485-1488. |
| [6] | Duncan CJA, Dinnigan E, Theobald R, et al. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20)[J]. Ann Rheum Dis, 2018, 77(5): 783-786. |
| [7] | Ohnishi H, Kawamoto N, Seishima M, et al. A Japanese family case with juvenile onset Beh?et's disease caused by TNFAIP3 mutation[J]. Allergol Int, 2017, 66(1): 146-148. |
| [8] | Shigemura T, Kaneko N, Kobayashi N, et al. Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Beh?et's disease[J]. RMD Open, 2016, 2(1): e000223. |
| [9] | Takagi M, Ogata S, Ueno H, et al. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome[J]. J Allergy Clin Immunol, 2017, 139(6): 1914-1922. |
| [10] | Franco-Jarava C, Wang H, Martin-Nalda A, et al. TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6[J]. Clin Immunol, 2018, 191: 44-51. |
| [11] | Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling[J]. Nature, 2004, 430(7000): 694-699. |
| [12] | Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity[J]. J Biol Chem, 2009, 284(13): 8217-8221. |
| [13] | Gans MD, Wang H, Moura NS, et al. A20 haplo-insufficiency presenting with a combined immunodeficiency[J]. J Clin Immunol, 2020, 40(7): 1041-1044. |
| [14] | Shaheen ZR, Williams SJA, Binstadt BA. Case report: a novel TNFAIP3 mutation causing haploinsufficiency of A20 with a lupus-like phenotype[J]. Front Immunol, 2021, 12: 629457. |
| [15] | Yu MP, Xu XS, Zhou Q, et al. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment[J]. World J Pediatr, 2020, 16(6): 575-584. |
| [16] | Wakatsuki R, Hatai Y, Okamoto K, et al. An infant with A20 haploinsufficiency presenting with periodic fever syndrome: A case report[J]. Int J Rheum Dis, 2023, 26(5): 973-976. |
| [17] | Aslani N, Asnaashari K, Parvaneh N, et al. TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases[J]. Pediatr Rheumatol Online J, 2022, 20(1): 78. |
| [18] | Jo KJ, Park SE, Cheon CK, et al. Haploinsufficiency A20 misdiagnosed as PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome with Kikuchi disease[J]. Clin Exp Pediatr, 2023, 66(2): 82-84. |
| [19] | He T, Huang Y, Luo Y, et al. Haploinsufficiency of A20 due to novel mutations in TNFAIP3[J]. J Clin Immunol. 2020, 40(5): 741-751. |
| [20] | Gudmundsson S, Singer-Berk M, Watts NA, et al. Variant interpretation using population databases: Lessons from gnomAD[J]. Hum Mutat, 2022, 43(8): 1012-1030. |
| [21] | Mahat U, Ambani NM, Rotz SJ, et al. Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent[J]. Pediatr Hematol Oncol. 2021, 38(7): 658-662. |
| [22] | Kingdom R, Wright CF. Incomplete penetrance and variable expressivity: from clinical studies to population cohorts[J]. Front Genet, 2022, 13: 920390. |
| [23] | Mitsunaga K, Inoue Y, Naito C, et al. A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide[J]. Rheumatology (Oxford), 2023, 62(6): e193-e195. |
| [24] | Shiraki M, Williams E, Yokoyama N, et al. Hematopoietic cell transplantation ameliorates autoinflammation in A20 haploinsufficiency[J]. J Clin Immunol, 2021, 41(8): 1954-1956. |
/
| 〈 |
|
〉 |
